Informa (LON:INF) Given Buy Rating at UBS Group
UBS Group reissued their buy rating on shares of Informa (LON:INF) in a research note published on Thursday morning, ThisIsMoney.Co.Uk reports.
Several other analysts have also commented on the company. Liberum Capital reiterated a buy rating on shares of Informa in a report on Monday, November 11th. Shore Capital upgraded Informa to a buy rating in a report on Friday, December 13th. Peel Hunt reiterated a hold rating on shares of Informa in a report on Thursday. Morgan Stanley reiterated an overweight rating and set a GBX 900 ($11.84) price objective on shares of Informa in a report on Monday, January 13th. Finally, HSBC decreased their price objective on Informa from GBX 970 ($12.76) to GBX 950 ($12.50) and set a buy rating for the company in a report on Monday, January 13th. One research analyst has rated the stock with a sell rating, five have given a hold rating and ten have issued a buy rating to the company’s stock. Informa currently has an average rating of Buy and an average target price of GBX 908 ($11.94).
Shares of INF traded up GBX 20 ($0.26) during midday trading on Thursday, hitting GBX 778.20 ($10.24). 2,851,842 shares of the company’s stock traded hands, compared to its average volume of 3,640,000. Informa has a 1 year low of GBX 689.40 ($9.07) and a 1 year high of GBX 900.80 ($11.85). The firm’s fifty day moving average is GBX 825.44 and its 200-day moving average is GBX 819.75. The company has a current ratio of 0.59, a quick ratio of 0.56 and a debt-to-equity ratio of 51.63. The stock has a market capitalization of $9.71 billion and a price-to-earnings ratio of 32.29.
Informa Company Profile
Informa plc engages in business intelligence, academic publishing, and knowledge and events businesses worldwide. The company operates through Academic Publishing, Business Intelligence, Global Exhibitions, and Knowledge & Networking segments. The Academic Publishing segment publishes academic books and journals in print and digital formats for university libraries and departments, specialist research institutions, and individuals in the areas of humanities and social sciences, science, technology, and medicine.
Further Reading: How Investors Can Profit from Options Trading
Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.